Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06293404Not yet recruiting
Randomised trial of bupivacaine in Hip fracture (2 arms), sponsored by Ankara City Hospital. Primary endpoints: Hemodynamic change at 10 months and Hemodynamic change blockade to the dependent lower limb at 30 months. Planned start Aug 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06293404.